JP2020506695A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020506695A5 JP2020506695A5 JP2019540667A JP2019540667A JP2020506695A5 JP 2020506695 A5 JP2020506695 A5 JP 2020506695A5 JP 2019540667 A JP2019540667 A JP 2019540667A JP 2019540667 A JP2019540667 A JP 2019540667A JP 2020506695 A5 JP2020506695 A5 JP 2020506695A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- vector
- raav
- recombinant
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022169032A JP2023002715A (ja) | 2017-01-30 | 2022-10-21 | 糖原病を処置するための組換えウイルスベクター |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762451963P | 2017-01-30 | 2017-01-30 | |
| US62/451,963 | 2017-01-30 | ||
| PCT/US2018/015957 WO2018140946A1 (en) | 2017-01-30 | 2018-01-30 | Recombinant virus vectors for the treatment of glycogen storage disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022169032A Division JP2023002715A (ja) | 2017-01-30 | 2022-10-21 | 糖原病を処置するための組換えウイルスベクター |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020506695A JP2020506695A (ja) | 2020-03-05 |
| JP2020506695A5 true JP2020506695A5 (https=) | 2021-02-25 |
Family
ID=61274327
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019540667A Pending JP2020506695A (ja) | 2017-01-30 | 2018-01-30 | 糖原病を処置するための組換えウイルスベクター |
| JP2022169032A Pending JP2023002715A (ja) | 2017-01-30 | 2022-10-21 | 糖原病を処置するための組換えウイルスベクター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022169032A Pending JP2023002715A (ja) | 2017-01-30 | 2022-10-21 | 糖原病を処置するための組換えウイルスベクター |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20190367944A1 (https=) |
| EP (1) | EP3574104A1 (https=) |
| JP (2) | JP2020506695A (https=) |
| AU (1) | AU2018212002A1 (https=) |
| CA (1) | CA3050917A1 (https=) |
| WO (1) | WO2018140946A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021012104A2 (pt) * | 2018-12-18 | 2021-09-08 | Ultragenyx Pharmaceutical Inc. | Métodos e composições para o tratamento de doenças de armazenamento de glicogênio |
| WO2023069891A1 (en) * | 2021-10-19 | 2023-04-27 | University Of Connecticut | Compositions and methods for the treatment of glycogen storage disorders |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| US6207455B1 (en) | 1997-05-01 | 2001-03-27 | Lung-Ji Chang | Lentiviral vectors |
| IL132463A0 (en) | 1997-05-13 | 2001-03-19 | Univ North Carolina | Lentivirus - based gene transfer vectors |
| US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| US6218181B1 (en) | 1998-03-18 | 2001-04-17 | The Salk Institute For Biological Studies | Retroviral packaging cell line |
| US6759050B1 (en) | 1998-12-03 | 2004-07-06 | Avigen, Inc. | Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| US6218186B1 (en) | 1999-11-12 | 2001-04-17 | Trustees Of The University Of Pennsylvania | HIV-MSCV hybrid viral vector for gene transfer |
| US7575924B2 (en) | 2000-11-13 | 2009-08-18 | Research Development Foundation | Methods and compositions relating to improved lentiviral vectors and their applications |
| RU2305708C2 (ru) | 2001-10-02 | 2007-09-10 | Энститю Клейтон Де Ля Решерш | Рекомбинантный лентивирусный вектор, клетка-хозяин, трансдуцированная лентивирусным вектором, способ ее трансдукции и применение |
| DE60333487D1 (de) | 2002-12-13 | 2010-09-02 | Genetix Pharmaceuticals Inc | Therapeutische retrovirus-vektoren für gentherapie |
| US20050261233A1 (en) * | 2004-04-21 | 2005-11-24 | Sanjay Bhanot | Modulation of glucose-6-phosphatase translocase expression |
| DK2185192T3 (en) | 2007-08-03 | 2019-02-18 | Pasteur Institut | LENTIVIRAL TRANSFER VECTORS AND THEIR MEDICAL USES |
| ES2751999T3 (es) | 2008-01-29 | 2020-04-02 | Applied Genetic Tech Corporation | Producción recombinante de virus adeno-asociados usando células BHK en suspensión |
| WO2010114948A2 (en) | 2009-04-02 | 2010-10-07 | University Of Florida Research Foundation, Inc. | An inducible system for highly efficient production of recombinant adeno-associated virus (raav) vectors |
| WO2011000373A1 (en) | 2009-06-30 | 2011-01-06 | Asp Technology Aps | Pause adviser system and use thereof |
| WO2011094198A1 (en) | 2010-01-28 | 2011-08-04 | The Children's Hospital Of Philadelphia Research Institute, Abramson Research Center | A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy |
| AU2014354839B2 (en) * | 2013-11-26 | 2020-06-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adeno-associated virus vectors for treatment of glycogen storage disease |
| WO2016106303A1 (en) * | 2014-12-23 | 2016-06-30 | THE UNITED STATES OF AMERICA, as representd by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Adeno-associated virus vectors encoding modified g6pc and uses thereof |
-
2018
- 2018-01-30 CA CA3050917A patent/CA3050917A1/en active Pending
- 2018-01-30 AU AU2018212002A patent/AU2018212002A1/en not_active Abandoned
- 2018-01-30 US US16/481,430 patent/US20190367944A1/en not_active Abandoned
- 2018-01-30 JP JP2019540667A patent/JP2020506695A/ja active Pending
- 2018-01-30 WO PCT/US2018/015957 patent/WO2018140946A1/en not_active Ceased
- 2018-01-30 EP EP18707167.5A patent/EP3574104A1/en not_active Withdrawn
-
2022
- 2022-10-21 JP JP2022169032A patent/JP2023002715A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016538885A5 (https=) | ||
| JP2024054426A5 (https=) | ||
| JP2019522461A5 (https=) | ||
| JP2018501791A5 (https=) | ||
| JP2014512171A5 (https=) | ||
| JP2010516252A5 (https=) | ||
| JP2018523668A5 (https=) | ||
| EP4272728A3 (en) | Adeno-associated virus variant capsids and use for inhibiting angiogenesis | |
| JP2020514286A5 (https=) | ||
| JP2021536244A5 (https=) | ||
| WO2019060454A3 (en) | Adeno-associated virus variant capsids and methods of use thereof | |
| JP2019521139A5 (https=) | ||
| CA3011874A1 (en) | Methods and compositions for rna-guided treatment of hiv infection | |
| JP2021526860A5 (https=) | ||
| WO2017197355A3 (en) | Adeno-associated virus variant capsids and methods of use thereof | |
| JP2020510447A5 (https=) | ||
| JP2019513794A5 (https=) | ||
| Zhan et al. | Vectored immunotherapeutics for infectious diseases: Can rAAVs be the game changers for fighting transmissible pathogens? | |
| JP2016537341A5 (https=) | ||
| JP2018532428A5 (https=) | ||
| JP2023536008A5 (https=) | ||
| JP2018515101A5 (https=) | ||
| JP2020503265A5 (https=) | ||
| JP2022505585A5 (https=) | ||
| JP2022501055A5 (https=) |